Article Information
History
- February 28, 2020.
Article Versions
- You are currently viewing Version 1 of this article (February 28, 2020 - 00:42).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Benjamin Demaree1,2,†,
- Cyrille L. Delley1,†,
- Harish N. Vasudevan1,3,
- Cheryl A.C. Peretz4,
- David Ruff5,
- Catherine C. Smith4 and
- Adam R. Abate1,2,6,*
- 1Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, USA
- 2UC Berkeley-UCSF Graduate Program in Bioengineering, University of California, San Francisco, California, USA
- 3Department of Radiation Oncology, University of California, San Francisco, California, USA
- 4Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, California, USA
- 5Mission Bio, Inc., San Francisco, California, USA
- 6Chan Zuckerberg Biohub, San Francisco, California, USA
- ↵*Correspondence to: Adam R. Abate, Ph.D., Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, 1700 4th St, San Francisco, California, USA; Email: adam{at}abatelab.org
↵† These authors contributed equally to this work.